Galmed Pharmaceuticals (GLMD) Other Accumulated Expenses (2022 - 2025)

Galmed Pharmaceuticals' Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $500000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses changed 0.0% year-over-year to $500000.0; the TTM figure through Dec 2025 stood at $500000.0 (changed 0.0% YoY), while the FY2025 annual figure was $500000.0, changed 0.0% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $500000.0, roughly flat from $500000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $600000.0 in Q4 2023, with the low at $78000.0 in Q1 2023.
• The 4-year median for Other Accumulated Expenses is $500000.0 (2024), against an average of $375600.0.
• The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses jumped 200.0% in 2023, then decreased 16.67% in 2024.
• Galmed Pharmaceuticals' Other Accumulated Expenses stood at $200000.0 in 2022, then surged by 200.0% to $600000.0 in 2023, then fell by 16.67% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025.
• Business Quant data shows GLMD's Other Accumulated Expenses at $500000.0 in Q4 2025, $500000.0 in Q4 2024, and $600000.0 in Q4 2023.